Fractional CMO

What Does a Fractional CMO Cost in Health & MedTech?

Clock Icon - Consultant Webflow Template
7

What Does a Fractional CMO Cost in Health & MedTech?

There is no universal fractional CMO price because the role can mean anything from a few hours of advisory work to embedded executive leadership over strategy, team, agencies, acquisition, budgeting, and board reporting.

For a health or MedTech company, the more useful question is not “What is the market rate?” It is “What level of leadership do we need, for how long, and what business problem is that leadership expected to solve?”

1. Why Healthcare Companies Use Fractional Marketing Leadership

A fractional CMO can make sense when a company needs senior marketing leadership but does not yet need, cannot justify, or is not ready to recruit a permanent full-time CMO.

Typical situations include:

  • a founder has outgrown tactical marketing management
  • multiple agencies or channels lack one accountable leader
  • a new product or market requires go-to-market leadership
  • the company is between senior marketing executives
  • a growth plateau requires diagnosis before more hiring
  • the team needs board-level marketing planning and reporting

2. The Main Pricing Models

Fractional CMO engagements commonly use one of several structures.

Monthly Retainer

A recurring fee for a defined level of executive involvement. The scope may include leadership meetings, team management, agency oversight, forecasting, campaign review, and strategic planning.

Fixed Project or Sprint

A defined engagement around a specific problem such as a growth audit, go-to-market plan, team redesign, positioning reset, or acquisition-economics review.

Interim Executive Engagement

A more intensive temporary role while the company recruits a permanent leader or moves through a transition.

Advisory Engagement

A lighter-touch structure focused on executive advice rather than day-to-day management.

These structures should not be compared as though they deliver the same amount of leadership.

3. What Actually Drives the Fee

The biggest cost drivers usually include:

  • hours and executive availability
  • number of direct reports or agencies managed
  • company size and complexity
  • number of products or markets
  • budget responsibility
  • regulated-product and healthcare experience needed
  • board or investor reporting
  • travel
  • duration and urgency

A fractional CMO who owns a $10 million marketing budget and leads multiple teams is a different role from an advisor attending two calls each month.

4. Health and MedTech Complexity Can Change the Scope

Healthcare marketing may require coordination with legal, regulatory, clinical, privacy, reimbursement, or quality teams.

Depending on the business, leadership may need to understand:

  • FDA device status and claim boundaries
  • FTC health-claim substantiation
  • HIPAA-related marketing data flows
  • telehealth state expansion
  • payer or employer channels
  • patient acquisition economics

That does not mean a CMO replaces legal, regulatory, or clinical experts. It means the marketing leader needs to build processes that work with them.

5. Compare the Cost With the Alternative You Would Actually Hire

A fractional role should be compared with the realistic alternative, not an arbitrary salary number from the internet.

The alternatives might be:

  • a full-time CMO
  • a VP of Marketing
  • an agency plus founder oversight
  • multiple channel specialists
  • an interim executive
  • doing nothing for six months

For each option, compare cash cost, recruiting time, leadership depth, management burden, speed, and flexibility.

6. Do Not Hire a Fractional CMO to Solve the Wrong Problem

A senior executive will not fix a company that lacks product-market fit, clinical capacity, adequate margins, capital, or a sellable offer simply by adding more marketing.

Before hiring, identify the constraint:

  • positioning
  • offer
  • traffic
  • conversion
  • sales
  • unit economics
  • retention
  • measurement
  • team
  • execution

The engagement should be built around the actual bottleneck.

7. How to Evaluate ROI

Do not require a fractional CMO to promise a precise revenue increase before seeing the business.

Instead, define measurable responsibilities such as:

  • improving forecast accuracy
  • reducing wasted spend
  • fixing attribution and reporting
  • improving funnel conversion
  • building a channel plan
  • hiring or restructuring the team
  • improving CAC and payback economics
  • launching a product or market

The ROI should be evaluated against contribution margin and enterprise priorities, not vanity revenue alone.

8. Questions to Ask Before Signing

  1. What decisions will this person own?
  2. How many hours and which meetings are included?
  3. Will they manage the team and agencies or only advise?
  4. What deliverables should exist after 30, 60, and 90 days?
  5. What metrics will determine success?
  6. What healthcare or regulated-market experience is relevant?
  7. What decisions still require legal, clinical, or regulatory specialists?
  8. What is the exit or transition plan for the engagement?

9. The Cost Question to Ask Instead

Instead of asking only, “How much does a fractional CMO cost?” ask:

What is the least expensive leadership structure capable of solving the growth problem without creating a larger one?

Sometimes that is a fractional CMO. Sometimes it is a VP, an agency, a project, or a permanent executive.

The Bottom Line

Fractional CMO pricing should follow scope, responsibility, complexity, and required leadership depth. A cheap engagement with no authority can be expensive if nothing changes. A larger engagement can be efficient if it replaces fragmented management and fixes the actual growth constraint.

For a broader comparison of healthcare fractional leadership economics, see Fractional CMO Cost in Healthcare.

See the Growth Clarity Diagnostic™

Charles Kirkland

Fractional CMO for Health and MedTech Brands

Fractional CMO leadership to grow $3M–$30M brands with precision, compliance, and profit. I specialize in FDA-regulated devices, telehealth, DTC, and platform-based health offers.